ONEXTEN

Welcome to the Brand page for “ONEXTEN”, which is offered here for Pharmaceutical preparations and substances for the treatment of diseases, illnesses, disorders, ailments or conditions of the central nervous system; pharmaceutical preparations and substances for the treatment of depression, depressive disorders and mental illnesses; antidepressants; pharmaceutical preparations and substances for the prevention, treatment, and alleviation of parkinson's disease; pharmaceutical preparations and substances for the prevention, treatment, and alleviation of huntington's disease; pharmaceutical preparations and substances for the prevention, treatment, and alleviation of amyotrophic lateral sclerosis; pharmaceutical preparations and substances for the prevention, treatment, and alleviation of alzheimer's disease; pharmaceutical preparations and substances for the prevention, treatment, and alleviation of epilepsy; pharmaceutical preparations and substances for the prevention, treatment, and alleviation of multiple sclerosis; pharmaceutical preparations and substances for the treatment of anxiety; and pharmaceutical preparations and substances for the prevention, treatment, and alleviation of pain;.

Its status is currently believed to be active. Its class is unavailable. “ONEXTEN” is believed to be currently owned by “VALEANT PHARMACEUTICALS IRELAND LIMITED”.